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Twenty-lt\t' years ago I attended m~ lir.;t me('t 
mg with thi~ SO{·iety Th(' pres1dentml address wns 
1(1\t'n by my Chief. Stepht-n Rothman !IJ. Consist 
ent with h1,., mterest,.,, the title wu ... "Basic H<' 
hearch in Dermatnlol{} He dtscusscd the enor 
mow .. problems that dermatology fo<'t•d in lind111g 
fund.., to condutt re!:.Nlrf h. All ...ourns of fundmg 
lur dermatolug•c re~>earth at that tun<' wC>re pmbn 
bh less than I " of what I he-. an• tndn) lie 
pleaded for mnre support 1;(1 that, 11.., he stated in 
the last line of his spct-ch, "we will knm' what 
psoriasil'- il'- · 
Has speech must han• been heard h\' d1stunt 
angeb becau,..e. a" we all know. rclat he), larl!e 
amounh ol money •mml'dl8tel~ !:.tartt·d to fl<m . not 
only into dermatolO!{It research. but mt11 biomNII 
rat re:..earch in genernl I would likt> to take this 
moment , fur all of ll'•. tnthank Dr Hothman for h1-.. 
seine""· trail-hla7in~ coni rihut ion" tn dermatoln~ 
and to reassure h1m that before anotht'r :?:) years 1(11 
hy "we will know w hut psona:..is iH." 
The prerogolive ol a presidential uddrel:'s i!-1 thtll 
1t '' ex cathedra Th1s fortunate di-..pensatlllll 
allnw:-; th~ ~ld~rl\' w mu!-1.' w1th 1mpun1t' helore th£" 
\'nung. I thank you for thll'- pnnle.:~ und antend 111 
tnk~ advantage oltt hy ea~tmg a lew 1d~a;, ahnut 
the eontrol of cutaneou-.. biology b) topic·al medic·n-
tion 
~1uch of mv time ho-. been con..,umed m the• 
pursuit of ,..olutllln' t11 problem" relat mg to pen·u 
Utneous absorpt •on. a fil'ld of enormnu!.. potent in I 
pract ira I value hut one whirh has nit racted onlv 11 
relati,ely small number of inve~t1gu1nrs Toda~. I 
want 111 relate some rlllher persnnnl ,·iewpmnh 
that I han nrquired in relation to lhl.'se pur!:.uih. 
There are t\\U rather d1,..tmct group~ of re~eanh 
ers in the field of perf ut nneous ahsorpt ion Thl'\ 
are prohahh best clu-.!..tfted a-.. the t heoretinun-. 
and the prarllt umers. 
The theorN il'ian-. are primanh phv>-J<·al ch<•m 
ISts who estnblish stn('l mathemnlll'Ol relnt1nn 
sh1ps of penNration hosed on genl'rnl thenr-. and 
obser\'atinn-.. ol "'mph~ membran£' ..,tructure!.. In 
general. the\· trv to avoid \Hirking '' ith human or 
ant mal :.kin hel'OU'-l' t he--l' pen er-.e mudels gener 
allv fail ln suhstanlinte their predit'tlllns based nn 
sampler system!. and thc•oretical modclo., 
The prac·t llwners havl.' to admit to the1r ~~ udit•s 
being mure on art than a suencl' hut the,· ha\e tlu: 
re-.pon-...btltt\ land the great advuntugf.'l ;,1 working 
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with a live, lunct ummg model Without detailed 
knowledge of higher mathemnl icl'- or phvsical 
chemi-..tn. the~e prnclllumers are best de~l·rtbed as 
belonging 10 the "apph and uh ... ern schtKII 
A It hough t hl'l'oe are gros..., O\er.impl it irnt 111ns, 
there 1s ment in lht!.. ch\'lsllln ancl I want tn 
emphasi1e that both schools ha\l' been prudul'll\1.'. 
The) 31'(' nm\ appn•arhlllg common J!mund \\htch 
make" the luture ot thts field appear parll~:ularly 
bright 
The ~!olden carrul before tht• nosl' ol the 111\C" 
tigator I!. the unbelie'tlhlv rich prnspert of t'ont rol 
hng normal and abnormal cutaneous tllologl( lUill' 
tinns h~ /(Jplcal apphl·at Jon;.. It a drug has a 
punirulnr phurmacologu or biolol{lc attl\ tt~ and It 
can penetrntt• the skill to reat·h the desired areu in 
the skill, we would hn\e the ideal pharmat·nlogic 
way 111 runt rol cutanenu-.. b10log1t' funrllnn. h<- It 
normal or abnormal. 
Let U'- ltMlk at a lmef ~umman of -..peuallu!llogtc 
functions of human skin !Table )). There nre 
litera II) volumes of informal ion em the ann tom), 
biochemiStn. phy,..iolo~') . pharmacolnj.,'). and pa~ 
tholo~ nl t hbe funcuun-... There· are largl' numbers 
of chemiral agents which haH profound ellet'h un 
many ol 1 he> I unct wns, vet prat·t icall) nnnl' 1s U~f.'d 
effectiH·I~ as a topical therapeutt(' agent Th1s is 
an ennrmnu" field \\hit'h '" nthl~ lallm\, nwnilllll{ 
the m\l' ... tlgator'-. ..,eed 
I would like to exemphty thh l"nncept hy pre-
senttng s<11ne exnmpl~ lrom our n\\n e"penem·e 
and that uf other" 
It ha-.. been knm\n lor over 'lll years thdl sweut 
delivc>n is a I'Wlction uf acet ~It holine and 1 hat a 
group ol drug~. churn(lerized hv atrnp1ne. are 
capahlt• nl inhibllmg oc·t•tylchuline lunct ion At -
tempts to anhibit li\\t'Oting b\ oraladmm~Siralum 
ol ant it hoi inergil·,.. c·au~l· ~e' ere• s1de effects he lure 
there'" an~ ;.1gnaht·nnt decrense in sweat in~: Thi:.. 
ammedintl'l~ suggests the po,..slbilat\ of nppl\ 1ng 
the anlll'hlllanergacs l~~t·all) to the -..km to cllrectly 
reach the sweat glands and 8\'0id s~·stermc toxil'ity. 
Let me put this into persperll\ e H\ mtradermal 
lllJecuon, nne can inhilnt a l:l.'i em' area ol -.kin 
with 0 II()()( I.) mg of at ropanc> An nral dn ... £' of 
atropine• unl' hundred thousand timt',.. as larg£" ''ill 
not signtficnntly inhihit sweating. 
A fe\\ lll\'t'~llgawrs haw -.tudll'd the I<>JHl'al 
eflec:ts of anticholinergll'" 12 II H\ altl'ring the 
parent .lllllcholmefl(lc' lllllle(·uk rmt can innease 
penetrution abuul IlK) and maintain urigmul 
binlngH· uc·t i\'it) I I. I J Thus. tlw henw~ I ('stt-r ol 
!>COpolamnw penelrates 100 timl's more effertl\el) 
than thl· parent ..,copolamine hydrohmm•de One 
can mhihit "''eaainJ,. \\lth a topit-ul ... otutinn of the 
benzoYl e,..ter m tht· <·um·entralinn Ill 0.01' ' Other 
t Stuu~:htnn RR linpuhlibhed nb,..rrvatwns 
:to:; 
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TABLE I 
Some bwlo11ic: functions of the ~krn 
Keratmization 
Melanization 
Reproduction of cells 
Differentiation of cells 
Sebaceous gland function 
Sweat gland functiOn 
Vascular control 
Collagen metabolihm 
Ground substance metabolism 
Apocrine gland function 
Sensory functions 
anticholinergtc agents behave similarly wtth re-
gard to changing penetration with minor molecular 
modification. 
The original studies with these special anti-
cholinergic-s revealed 100' , inhibit ton of forearm 
sweating with no systemic toxicity and hopes were 
high for complete -control of sweating by topical 
use. However, when applied to the axillae. thebe 
agents were only about 50', effective [:3, 4 ]. WI. at ib 
the reason for this? Tt is probably due to the fact 
that the eccrine !meat glands of the axillan· vault 
tend to be deeper in the dermi~ as compared to the 
forearm so that much of the absorbed antirholiner-
gic is inactivated and/or rarried away by the 
circulation before it can reach the sweat glands 
(Fig. ll. 
Another area for practic-al u~e of anticholincrgics 
would be on the palms and ;;ole~ of those with 
hyperhidrosis. Dtrect experimentatiOn wtth vari-
ous anticholinergics, such as atropine, even with 
high concentrations in special vehicles such as 
dimethylsulfoxide. revealed that no inhibition of 
sweaung of the palms or ,.,o(es could be obtained 
by topical application (Fig. 21. Direct injection of 
the anticholinergi(• into the corium of the palm or 
sole did totally inhibit sweat mg. Thu,., the problem 
is probably in the thick stratum corneum of the 
palm and sole, which serves as a major barrier to 
penetration ol the pharmacologic agent. 
The abo,·e example demon~trate~ the potential 
of controlling a biologic function of skin by topical 
pharmacology but at the same time it elucidates 
the secondarv problems such as penetration of a 
thick stratum corneum and deliven of the phar-
macologic agent to deep structures of the skin 
when having to bypa~s the cin·ulation. binding 
facto~. metabolic breakdown, etc. on the wa) from 
the surface to the deeper layers oft he corium. 
Referring back to Table l we note melanin 
pigment formation. Probably more 1s knmvn about 
this process than any other in human skin . De-
tailed biochemical schemes for the formation of 
melanin have been kno,,n for over -10 years. The 
structure and function of melanocyte~ is intimately 
understood and new work in the area repeatedly 
occupies a sizeable port ion of each new issue of 
ANTI CHOU N fiZGIC 
furoJrm axilla 
FtG. 1: Anticholinergics inhibit sweattng only 50% by 
topical application to the axilla a-; compared to 100~ 
inhibition on the forearm. Th1s appearl> to be due to the deep anatomic location of some of the eccrine sweat glands in the axilla. 
Af:ropine 10% 
inOMSO 
0 .. ~ 
0 0 0 0 
> 0 
0 
Ftc. 2: Anticholinergics in high concentration in 
highly penetrant vehicles are not effective topically on 
the palm because of blockinl( by the thick stratum 
corneum. Atropine intradermally in the palm inhibits 
sweating at very low concentration. 
dermatology journals and many others as well. The 
hormonal mediators and regulators of melanin 
formation are now common knowledge. There are 
reports of topical chemical agents which depig-
ment the skin of man as well as those which induce 
hyperpigmentat ion. 
In spite of all of this in format ion, we do not ha,·e 
a satisfactory therapeutic program for topically 
controlling pigmentation in the skin of man. It is 
not easy to account for why this is so, but I suspect 
it is more for the lack of imaginative expenmenta-
tton with current information than for any other 
reason. As an example. I do not knO\\ of any 
attempts to control melanm formation by topical 
application or intracutaneous inject icm of melanin-
stimulating hormone (MSH). This would be par-
ticularly interesting to try. in ,-iew of Lerner's work 
showing rapid and dramatic darkening of human 
skin with systemic administration of MSH [5 ]. 
There has been no successful attempt to increase 
pigment by topically applying agents which would 
be expected to promote t)rosinase actiYity in the 
melanocyte or interfere with the well-known bio-
chemical sequence which carries tyrosine to its 
subsequently polymerized structure in melanin. 
One might refer to Table 1 again to select 
collagen metaboli~m a~ an area of almost total 
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neglect lmm the "tandpoint of topical control of its 
functions . There is the indiret·t experience with 
topical gl urororticoslerolds, in \\ hich atrophy and 
purpura may develop, hut this Is not a therapeutic 
application . With current detailed biochemical 
information of the specific enzymatic processes uf 
collagen formation, degradation. cross-linking, and 
hydroxylation. one should start thinking oltrvmg 
to control conditions such as scars. keloids. and 
scleroderma with the top1cal application ol agents 
such as penicillamine . .d-aminopropionitrile. and 
collagenase which interfere with collagen forma-
tion at specific points [6]. 
The topical l'ontrol of reproduction of epidermal 
cell-. has been an area of recent interest in regard w 
psoriasi:-., actinic keratoses. and cutaneous malig-
nancy. The new era of cell biolo!!Y and its exponen-
tial advance;. ha\e stimulated im estigators to 
probe the po:;sible control ol hyperproliferauve 
epidermal disease by topical application:-. of agents 
known to inhibit cell duplit·atwn . The topical 
5 -fluorouracil story in control of actinic keratose;. is 
a landmark in the progress of topical therapy of 
skin diseases and an excellent example of the type 
ol success that can be achieved by rational applica-
tion of known pharmacologic agents to topical 
management of skin di!ieases . Quite perplexing 1;. 
wh)' such agents as methotrexate. triacetvl azari -
bine. C) tosine arabinoside. and hydroxyurea. 
which seem to be effective m psoriasis by systemic 
application, are essentially inelfecti\·e by topical 
application. It is known that methotrexate pene-
trates human skin in amounts more than sufficient 
for pharmacologic activit)' at the cellular level [71 
and that it will inhibit deoxvuridine uptake into 
D~ A [81 by this rout e. but still there i;. no evidence 
of resolution of the psoriatic plaque by top1cal 
application of methotrexate. On the other hand. 
topical 5-fluorouracil definitely cau~es resolution 
of psoriatic plaques [9. l 0 I and can be shown to 
penetrate human skin in amounts more than 
adequate to explain t he biologic activity observed 
after topical application [ll]. Unexplained is why 
5-f1uorouracil has such a low order of acti\ ity on 
normal epidermis in vivot . 
o it becomes obvious that the success of topical 
pharmacologic agent depends not only on pene-
tration of the stratum corneum but on a myriad of 
other factors such as bmdmg, metabolic break-
down. and removal by circulation. that can intt>r-
fere with the intended activity of the topically 
applied agent. 
The com·erse of these ohservations might he 
mentioned with regard to agents given .;ystemi-
cally for control of skin disease. It is generally 
assumed that such systemic agents will affect 
mnm other organs as \\ell a:-. skin. and again 
methotrexate is a good example . However, practi-
cally no attention (or certainly success) has been 
given to the possibility of designing s~•stemic drugs 
so that they would be activated only in the skin. 
The skin has unique metabolic systems (melanin, 
keratinization, sweat glands. sebaceou~ glands) 
which might be utilized to acti\'ate, only in the 
skin. an otherwise totally inactive derivative. For 
example. 1f cvclopho;.pharmde could be romplexed 
with an inactivating molecule which could be split 
off only by an enzyme found in skin or more 
specifically, epidermal cells, a d rug designed spe-
cifically for one area of action would be realized, 
with all its obvious ad\'antages. 
Another tempting area for speculation is that of 
sebaceous gland function. The biomechanics of 
acne have been developed into a good working 
hypothesis [14]. The role~:> of bacteria, sebum, and 
hormones are reasonably well outlined in theory 
and suggest. in turn, specific modes of approach in 
topical therapy. The sebaceous gland is a target 
organ for testosterone. Existing knowledge from 
sophisticated hormonal research (15] can delineate 
a few chemical agents which could be expected to 
block this hormonal action at the level ol the 
sebaceou gland. ~ uch a!{ents have been reported 
[If). l'i] in detail. These agents could be applied 
topically to limited areas with no significant sy -
temic effect (Fig. :3) . \\'hy can't antibiotics or 
simple antimicrobial agents be made to penetrate 
the follicles and comedones to obliterate the orga-
nisms which are thought to induce the disease (Fig . 
.tl? . ophisticated, modem !:>tudies of follicular 
penetration are nonexistent yet. in theory. it 
should be possibll' to design vehicles and specific 
antibiotics for follit·ular and comedonal penetra-
tion. These approaches to acne offer rational ave-
nues to the l'Ontrol of a very common problem 
which has. so far, yielded minimally and reluc-
tantly to the ministration:-. of phy!.ician;.. 
Our current methods for controlling hair growth 
are remarkable for the1r impotence. Generally. if 
hair falls where we don't want it to. \\ e can't grow it 
there. If hair grow ... where it isn't wanted. we can't 
stop it. Yet. we are very knowledgeable about the 
chemistry and physiology of hair growth. Let us 
examine just one problem, that of hypert richosis. 
from the viewpoint of potential topical control. It 
has been known for years that ionizing radial ion, 
antimetabolites, and heparin . a well as illness can 
BLO'k. TESTOSTERO~E 
F IG. 3: Agents that specifically inhibit hormonal stim-
ulation of the sebaceous gland target organ should be 
acuve topically if they can be made to reach the target 
organ. 
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F1c. 4: Antibiotics might be very effective topically in 
controlling acne if they could be made to penetrate 
follicles and comedones where C. acnes resides. 
induce hair loss in follicles which are actively 
producing hair, pre!>umably due to temporary 
interference with the cell eyrie of the extremely 
active cells in the hair bulb. Because this loss can 
be temporary. with regeneration of perfectly nor-
mal hairs and no permanent damage to the folli -
cles. one won den. why topical antimetabolite;, ha\ e 
not been introduced to control excessive or un-
desirable hair growth, such a;, that found on the 
face of some of our female patients who plead for 
help. With a rising mterest in the top1cal control of 
hyperproliferative states such as psoriasis, we may 
be able to extend these inve!;tigations 2-4 mm 
lower in the corium to the hair bulbs. Jt might be 
mentioned here that one intradermal injection of 
5-11uorouracil will stop hair growth in the chin-
chilla rabbit for at least 21 days, without any 
detectable harmful effect:. to the other cutaneous 
structure!' 
Because of the difficulty in obtaining sufficient 
human skin for in vivo and in vitro percutaneous 
penetration s tudies, lahoratorv animals are fre-
quently used for such ~tudie:.. l 'nfortunate ly there 
are ven few direl't compari;,on studies of huma n 
and animal skin so that the re lationships between 
penetration ol human and ammal skin for any 
given agent are not ver\' dear. A few studies ha,·e 
been done [UU8.19) It appear-. that hairle'>s 
mouse !;kin is quite similar to human ;,kin, particu-
larly in its quantitative relationship in vitro [20). 
Table II represents ~o.ome of our own observations of 
quantitative penetration of given chemicals 
through human and hairless mouse !'kin. We prefer 
to work with hairlesl:> mice as a rough screening 
model and to save human s kin for critical tests of 
those agents which appear interesting in hairless 
mouse !>tudies. 
What is desperately needed to hricige the painful 
and frustrating gap bet ween existing knowledge 
and its application to topical control of cutaneous 
biology is encouragement to group!; of competent 
investigator!> to enter and expand this field . Thi!> 
fascinating area has room for theoretician . bal:>ic 
scientist::~, and conventional clinical researchen<. It 
has a large and rewarding future. The disea:.es 
TABLE n 
Percent penetrallon of human and hair/e,\s mouse skm rn 
24 hours !in uitro) 
Human· 
H• Betamethasone 17-valerate 0.7'l 0.8'l 
0.001 M 
H• Betamethasone alcohol 0.1>01 M 0.7"< 0.9% 
C" Thiabendazole 0.5~ 9.4~ 14 .6'l 
C" Tolnaftate 0.5~ 0.9% 1.4'l 
C" Hydrocortisone alcohol 1.3'1; 1.9% 
C" 5- Fluoroura('J( 14.2'!f 16.l 'l 
• ormal-appeanng ~kin from legs amputated for 
tumor, trauma, or gangrene. 
await cures that are already "on the shell." I hope 
some of you will agree and gi\'e it a try . 
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